This study is currently not recruiting participants.

Long-term Outcomes of Infants with IUDE to Buprenorphine and Methadone

J
Jo Ann Matory, MD

Primary Investigator

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study

The purpose of this study is to investigate if children born to women who received who were receiving opioid maintenance therapy through one of the following medications: methadone or buprenorphine or buprenorphine/naloxone combination drug during pregnancy will demonstrate increased number of health care provider and medical interventions and lower behavioral assessment scores with delayed motor development when compared with established acceptable normative scorings.

Detailed description of study

The purpose of this study is to investigate if children born to women who received who were receiving opioid maintenance therapy through one of the following medications: methadone or buprenorphine or buprenorphine/naloxone combination drug during pregnancy will demonstrate increased number of health care provider and medical interventions and lower behavioral assessment scores with delayed motor development when compared with established acceptable normative scorings.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: 100 years or below
  • Gender: All
Updated on 29 Jan 2018. Study ID: 1710802432

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the Study Team